Clinical features and prognosis of autoimmune hepatitis patients with different sexes

Huili WU; Hongbo SHI; Yanmin LIU; Mei DING; Zhenglai MA; Shuang LIU; Yu CHEN; Zhongping DUAN

doi:10.3969/j.issn.1001-5256.2021.07.031

Volume 37 Issue 7

Jul. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(7): 1636-1643

PDF( 2040 KB)

Clinical features and prognosis of autoimmune hepatitis patients with different sexes

DOI: 10.3969/j.issn.1001-5256.2021.07.031

a.
Intractable Hepatic Diseases and Artificial Liver Treatment & Training Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
b.
Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
c.
Department of Immunopathy and Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
d.
Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China

Research funding:

National Key R & D Program of China (2017YFA0103000);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2012ZX10002004-006);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2017ZX10203201-005);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2017ZX10201201-001-001);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2017ZX10201201-002-002);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2017ZX10201201-004-002);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2017ZX10202203-006-001);

National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Preventon and Treatment" (2017ZX10302201-004-002);

"Beijing Muncipal Administration of Hospitals" Ascent Plan (DFL20151601);

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201806);

Science and Technology Innovation Service Capacity Building-high-precision Discipline Construction Project (11920703);

Open Research Project of Key Laboratory of Capital Medical University (BJYAHKF2017008)

Received Date: 2020-12-27
Accepted Date: 2021-01-20
Published Date: 2021-07-20

Abstract

Abstract

Objective To investigate the differences between autoimmune hepatitis (AIH) patients with different sexes, since AIH is more common in female individuals and there are few studies on male AIH patients. Methods A retrospective analysis was performed for 398 patients who were hospitalized in Beijing YouAn Hospital from October 2009 to October 2019 and were diagnosed with AIH, and the patients were divided into female group and male group according to sex. General status, clinical features, and prognosis were analyzed. The primary outcome measure was death or liver transplantation. The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups. The Cox proportional hazards model was used to perform univariate and multivariate analyses. Results As for age, the peak of disease onset was observed in patients aged 51-60 years in both male and female groups, and compared with the female group, the male group had a significantly higher rate of confirmed diagnosis at the age of 21-30 years (8/48 vs 24/334, χ²=4.915, P=0.027) and a significantly lower rate of confirmed diagnosis at the age of 41-50 years (7/48 vs 97/334, χ²=4.428, P=0.035). As for AIH, compared with the female group, the male group had a significantly higher proportion of patients with idiopathic AIH (31/48 vs 170/350, χ²=4.329, P=0.037) and a significantly lower proportion of patients with other autoimmune diseases, especially hyperthyroidism (0/48 vs 39/348, P=0.008). As for laboratory examination, compared with the female group, the male group had significantly lower positive rates of anti-nuclear antibody (ANA)≥1∶ 100(42/48 vs 325/340, χ²=5.375, P=0.020) and SSA/SSB (2/48 vs 76/340, χ²=7.566, P=0.006), as well as a significantly lower proportion of patients with ANA ≥1∶ 1000 (P < 0.000 1). As for prognosis, compared with the female group, the male group had a significantly younger age at the time of death or liver transplantation (31.5±15.9 years vs 53.9±12.6 years, t=3.798, P=0.001) and a significantly higher proportion of patients with decompensated liver cirrhosis or hepatocellular carcinoma (both P < 0.05). Diabetes, liver cirrhosis, and blood albumin < 31.4 g/L were high-risk factors for reduced survival time in male patients, and liver failure, liver cirrhosis, ANA ≥1∶ 1000, direct bilirubin > 42 μmol/L, lymphocyte count < 1.2×10⁹/L, and C3 < 0.588 g/L were high-risk factors for reduced survival time in female patients. Conclusion Sex difference has certain influence on the clinical manifestations and prognosis of AIH patients, and male patients tend to have a younger age and a poorer prognosis.
- Hepatitis, Autoimmune,
- Gender,
- Signs and Symptoms,
- Prognosis

FullText(HTML)

References(36)

References

[1]	European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis[J]. J Hepatol, 2015, 63(4): 971-1004. DOI: 10.1016/j.jhep.2015.06.030.
[2]	TAUBERT R, JAECKEL E. Autoimmunhepatitis-Standard- und Zweitlinientherapie [Autoimmune hepatitis-standard and second-line therapy][J]. Internist (Berl), 2018, 59(6): 536-543. DOI: 10.1007/s00108-018-0434-1.
[3]	PUUSTINEN L, BOYD S, MUSTONEN H, et al. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis[J]. Scand J Gastroenterol, 2017, 52(3): 321-327. DOI: 10.1080/00365521.2016.1253768.
[4]	∅RSTAVIK KH. Why are autoimmune diseases more prevalent in women?[J]. Tidsskr Nor Laegeforen, 2017, 137(12-13): 866-868. DOI: 10.4045/tidsskr.16.0935.
[5]	LIBERT C, DEJAGER L, PINHEIRO I. The X chromosome in immune functions: When a chromosome makes the difference[J]. Nat Rev Immunol, 2010, 10(8): 594-604. DOI: 10.1038/nri2815.
[6]	MOULTON VR. Sex hormones in acquired Immunity and autoimmune disease[J]. Front Immunol, 2018, 9: 2279. DOI: 10.3389/fimmu.2018.02279.
[7]	RIBBONS KA, MCELDUFF P, BOZ C, et al. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS[J]. PLoS One, 2015, 10(6): e0122686. DOI: 10.1371/journal.pone.0122686.
[8]	ABDULKARIM M, ZENOUZI R, SEBODE M, et al. Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis[J]. Scand J Gastroenterol, 2019, 54(11): 1391-1396. DOI: 10.1080/00365521.2019.1683226.
[9]	LUCEY MR, NEUBERGER JM, WILLIAMS R. Primary biliary cirrhosis in men[J]. Gut, 1986, 27(11): 1373-1376. DOI: 10.1136/gut.27.11.1373.
[10]	SAYINER M, GOLABI P, STEPANOVA M, et al. Primary biliary cholangitis in medicare population: The impact on mortality and resource use[J]. Hepatology, 2019, 69(1): 237-244. DOI: 10.1002/hep.30174.
[11]	SHAHARIR SS, KADIR WDA, NORDIN F, et al. Systemic lupus erythematosus among male patients in Malaysia: How are we different from other geographical regions?[J]. Lupus, 2019, 28(1): 137-144. DOI: 10.1177/0961203318812676.
[12]	AL-CHALABI T, UNDERHILL JA, PORTMANN BC, et al. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis[J]. J Hepatol, 2008, 48(1): 140-147. DOI: 10.1016/j.jhep.2007.08.013.
[13]	MONTANO-LOZA AJ, CARPENTER HA, CZAJA AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis[J]. Am J Gastroenterol, 2008, 103(8): 1944-1951. DOI: 10.1111/j.1572-0241.2008.01922.x.
[14]	DONET JA, PERLINI EF, GILINSKY D, et al. Impact of gender on clinical presentation, response to treatment, and long-term outcomes in an ethnically diverse population of patients with autoimmune hepatitis[J]. J Hepatol, 2016, 64(2): s439. http://www.researchgate.net/publication/308577254_Impact_of_Gender_on_Clinical_Presentation_Response_to_Treatment_and_Long-Term_Outcomes_in_an_Ethnically_Diverse_Population_of_Patients_with_Autoimmune_Hepatitis
[15]	HENNES EM, ZENIYA M, CZAJA AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology, 2008, 48(1): 169-176. DOI: 10.1002/hep.22322.
[16]	ALVAREZ F, BERG PA, BIANCHI FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31(5): 929-938. DOI: 10.1016/s0168-8278(99)80297-9.
[17]	WEILER-NORMANN C, SCHRAMM C. Drug induced liver injury and its relationship to autoimmune hepatitis[J]. J Hepatol, 2011, 55(4): 747-749. DOI: 10.1016/j.jhep.2011.02.024.
[18]	YEONG TT, LIM KH, GOUBET S, et al. Natural history and outcomes in drug-induced autoimmune hepatitis[J]. Hepatol Res, 2016, 46(3): e79-e88. DOI: 10.1111/hepr.12532.
[19]	CHAZOUILLÈRES O, WENDUM D, SERFATY L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy[J]. Hepatology, 1998, 28(2): 296-301. DOI: 10.1002/hep.510280203.
[20]	BOBERG KM, CHAPMAN RW, HIRSCHFIELD GM, et al. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue[J]. J Hepatol, 2011, 54(2): 374-385. DOI: 10.1016/j.jhep.2010.09.002.
[21]	FUKUI H, SAITO H, UENO Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015[J]. J Gastroenterol, 2016, 51(7): 629-650. DOI: 10.1007/s00535-016-1216-y.
[22]	GRR∅NBAK L, VILSTRUP H, JEPSEN P. Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study[J]. J Hepatol, 2014, 60(3): 612-617. DOI: 10.1016/j.jhep.2013.10.020.
[23]	XUE M, SHEN Y, SHEN MY, et al. Autoimmune hepatitis-related autoantibodies and their clinical significance[J]. J Clin Hepatol, 2019, 35(6): 1392-1396. DOI: 10.3969/j.issn.1001-5256.2019.06.048. 雪梅, 沈怡, 沈梦益, 等. 自身免疫性肝炎相关自身抗体及临床意义[J]. 临床肝胆病杂志, 2019, 35(6): 1392-1396. DOI: 10.3969/j.issn.1001-5256.2019.06.048.
[24]	ZHANG WC, ZHAO FR, CHEN J, et al. Meta-analysis: Diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis[J]. PLoS One, 2014, 9(3): e92267. DOI: 10.1371/journal.pone.0092267.
[25]	CZAJA AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis[J]. J Hepatol, 1999, 30(3): 394-401. DOI: 10.1016/s0168-8278(99)80096-8.
[26]	DINSER R, BRAUN A, JENDRO MC, et al. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms[J]. Scand J Rheumatol, 2007, 36(6): 448-451. DOI: 10.1080/03009740701406577.
[27]	VALGEIRSSON KB, HREINSSON JP, BJÖRNSSON ES. Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs[J]. Liver Int, 2019, 39(12): 2341-2349. DOI: 10.1111/liv.14224.
[28]	FLOREANI A, DE MARTIN S, SECCHI MF, et al. Extrahepatic autoimmunity in autoimmune liver disease[J]. Eur J Intern Med, 2019, 59: 1-7. DOI: 10.1016/j.ejim.2018.10.014.
[29]	MURATORI P, FABBRI A, LALANNE C, et al. Autoimmune liver disease and concomitant extrahepatic autoimmune disease[J]. Eur J Gastroenterol Hepatol, 2015, 27(10): 1175-1179. DOI: 10.1097/MEG.0000000000000424.
[30]	WONG GW, YEONG T, LAWRENCE D, et al. Concurrent extrahepatic autoimmunity in autoimmune hepatitis: Implications for diagnosis, clinical course and long-term outcomes[J]. Liver Int, 2017, 37(3): 449-457. DOI: 10.1111/liv.13236.
[31]	GOWER E, ESTES C, BLACH S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection[J]. J Hepatol, 2014, 61(1 Suppl): S45-S57. DOI: 10.1016/j.jhep.2014.07.027.
[32]	REZAEE ZAVAREH MS, ALAVIAN SM, KARIMISARI H, et al. Occult hepatitis C virus infection in patients with autoimmune hepatitis[J]. Hepat Mon, 2014, 14(8): e16089. DOI: 10.5812/hepatmon.16089.
[33]	MENG J. Epidemiological survey of hepatitis B virus infection in hospitals: A cross-sectional study[D]. Changchun: Jilin University, 2016. 孟静. 乙型肝炎病毒感染医院流行病学调查: 一项横断面研究y[D]. 长春: 吉林大学, 2016.
[34]	TAUBERT R, DIESTELHORST J, JUNGE N, et al. Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis[J]. Sci Rep, 2018, 8(1): 17452. DOI: 10.1038/s41598-018-35882-7.
[35]	PARKER R, OO YH, ADAMS DH. Management of patients with difficult autoimmune hepatitis[J]. Therap Adv Gastroenterol, 2012, 5(6): 421-437. DOI: 10.1177/1756283X12450251.
[36]	TANSEL A, KATZ LH, EL-SERAG HB, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: A systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2017, 15(8): 1207-1217.e4. DOI: 10.1016/j.cgh.2017.02.006.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(6)

Get Citation

PDF

XML

Article Metrics

Article views (533) PDF downloads(47)

Clinical features and prognosis of autoimmune hepatitis patients with different sexes

DOI: 10.3969/j.issn.1001-5256.2021.07.031

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical features and prognosis of autoimmune hepatitis patients with different sexes

DOI: 10.3969/j.issn.1001-5256.2021.07.031

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content